EXHIBIT A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Dyne Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 8th day of February, 2023.
MPM BIOVENTURES 2018, L.P. | ||
By: | MPM BioVentures 2018 GP LLC, | |
its General Partner | ||
By: | MPM BioVentures 2018 LLC, | |
Its Managing Member | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Managing Director | |
MPM BIOVENTURES 2018 (B), L.P. | ||
By: | MPM BioVentures 2018 GP LLC, | |
its General Partner | ||
By: | MPM BioVentures 2018 LLC, | |
Its Managing Member | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Managing Director | |
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | ||
By: | MPM BioVentures 2018 LLC, | |
Its Manager | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Managing Director | |
MPM BIOVENTURES 2018 GP LLC | ||
By: | MPM BioVentures 2018 LLC, | |
Its Managing Member | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Managing Director |
Page 15 of 16
MPM BIOVENTURES 2018 LLC | ||
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
Title: | Managing Director | |
By: | /s/ Todd Foley | |
Name: | Todd Foley | |
By: | /s/ Luke Evnin | |
Name: | Luke Evnin | |
By: | /s/ Ansbert Gadicke | |
Name: | Ansbert Gadicke | |
By: | /s/ Edward Hurwitz | |
Name: | Edward Hurwitz |
Page 16 of 16